ESEmma Schwager

Emma Schwager

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emma Schwager has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Multivariable association discovery in population-scale meta-omics studies

    by Himel Mallick, Ali Rahnavard, Lauren J. McIver, Siyuan Ma, Yancong Zhang, Long H. Nguyen, Timothy L. Tickle, George Weingart, Boyu Ren, Emma H. Schwager, et al.

    It is challenging to associate features such as human health outcomes, diet, environmental conditions, or other metadata to microbial community measurements, due in part to their quantitative properties. Microbiome multi-omics are typically noisy, sparse (zero-inflated), high-dimensional, extremely non-normal, and often in the form of count or compositional measurements. Here we introduce an optimized combination of novel and established methodology to assess multivariable association of microbial community features with complex metadata in population-scale observational studies. Our approach, MaAsLin 2 (Microbiome Multivariable Associations with Linear Models), uses generalized linear and mixed models to accommodate a wide variety of modern epidemiological studies, including cross-sectional and longitudinal designs, as well as a variety of data types (e.g., counts and relative abundances) with or without covariates and repeated measurements. To construct this method, we conducted a large-scale evaluation of a broad range of scenarios under which straightforward identification of meta-omics associations can be challenging. These simulation studies reveal that MaAsLin 2’s linear model preserves statistical power in the presence of repeated measures and multiple covariates, while accounting for the nuances of meta-omics features and controlling false discovery. We also applied MaAsLin 2 to a microbial multi-omics dataset from the Integrative Human Microbiome (HMP2) project which, in addition to reproducing established results, revealed a unique, integrated landscape of inflammatory bowel diseases (IBD) across multiple time points and omics profiles.


  • Estimation of Baseline Serum Creatinine with Machine Learning

    by Erina Ghosh, Larry Eshelman, Stephanie Lanius, Emma Schwager, Kalyan S. Pasupathy, Erin F. Barreto, Kianoush Kashani

    Introduction: Comparing current to baseline serum creatinine is important in detecting acute kidney injury. In this study, we report a regression-based machine learning model to predict baseline serum creatinine. Methods: We developed and internally validated a gradient boosting model on patients admitted in Mayo Clinic intensive care units from 2005 to 2017 to predict baseline creatinine. The model was externally validated on the Medical Information Mart for Intensive Care III (MIMIC III) cohort in all ICU admissions from 2001 to 2012. The predicted baseline creatinine from the model was compared with measured serum creatinine levels. We compared the performance of our model with that of the backcalculated estimated serum creatinine from the Modification of Diet in Renal Disease (MDRD) equation. Results: Following ascertainment of eligibility criteria, 44,370 patients from the Mayo Clinic and 6,112 individuals from the MIMIC III cohort were enrolled. Our model used 6 features from the Mayo Clinic and MIMIC III datasets, including the presence of chronic kidney disease, weight, height, and age. Our model had significantly lower error than the MDRD backcalculation (mean absolute error [MAE] of 0.248 vs. 0.374 in the Mayo Clinic test data; MAE of 0.387 vs. 0.465 in the MIMIC III cohort) and higher correlation (intraclass correlation coefficient [ICC] of 0.559 vs. 0.050 in the Mayo Clinic test data; ICC of 0.357 vs. 0.030 in the MIMIC III cohort). Discussion/Conclusion: Using machine learning models, baseline serum creatinine could be estimated with higher accuracy than the backcalculated estimated serum creatinine level.


  • Open Access

    A statistical model for describing and simulating microbial community profiles

    by Siyuan Ma, Boyu Ren, Himel Mallick, Yo Sup Moon, Emma Schwager, Sagun Maharjan, Timothy L. Tickle, Yiren Lu, Rachel N. Carmody, Eric A. Franzosa, et al.

    Many methods have been developed for statistical analysis of microbial community profiles, but due to the complex nature of typical microbiome measurements (e.g. sparsity, zero-inflation, non-independence, and compositionality) and of the associated underlying biology, it is difficult to compare or evaluate such methods within a single systematic framework. To address this challenge, we developed SparseDOSSA (Sparse Data Observations for the Simulation of Synthetic Abundances): a statistical model of microbial ecological population structure, which can be used to parameterize real-world microbial community profiles and to simulate new, realistic profiles of known structure for methods evaluation. Specifically, SparseDOSSA’s model captures marginal microbial feature abundances as a zero-inflated log-normal distribution, with additional model components for absolute cell counts and the sequence read generation process, microbe-microbe, and microbe-environment interactions. Together, these allow fully known covariance structure between synthetic features (i.e. “taxa”) or between features and “phenotypes” to be simulated for method benchmarking. Here, we demonstrate SparseDOSSA’s performance for 1) accurately modeling human-associated microbial population profiles; 2) generating synthetic communities with controlled population and ecological structures; 3) spiking-in true positive synthetic associations to benchmark analysis methods; and 4) recapitulating an end-to-end mouse microbiome feeding experiment. Together, these represent the most common analysis types in assessment of real microbial community environmental and epidemiological statistics, thus demonstrating SparseDOSSA’s utility as a general-purpose aid for modeling communities and evaluating quantitative methods. An open-source implementation is available athttp://huttenhower.sph.harvard.edu/sparsedossa2.


  • Open Access

    Utilizing machine learning to improve clinical trial design for acute respiratory distress syndrome

    by E. Schwager, K. Jansson, A. Rahman, S. Schiffer, Y. Chang, G. Boverman, B. Gross, M. Xu-Wilson, P. Boehme, H. Truebel, et al.

    Heterogeneous patient populations, complex pharmacology and low recruitment rates in the Intensive Care Unit (ICU) have led to the failure of many clinical trials. Recently, machine learning (ML) emerged as a new technology to process and identify big data relationships, enabling a new era in clinical trial design. In this study, we designed a ML model for predictively stratifying acute respiratory distress syndrome (ARDS) patients, ultimately reducing the required number of patients by increasing statistical power through cohort homogeneity. From the Philips eICU Research Institute (eRI) database, no less than 51,555 ARDS patients were extracted. We defined three subpopulations by outcome: (1) rapid death, (2) spontaneous recovery, and (3) long-stay patients. A retrospective univariate analysis identified highly predictive variables for each outcome. All 220 variables were used to determine the most accurate and generalizable model to predict long-stay patients. Multiclass gradient boosting was identified as the best-performing ML model. Whereas alterations in pH, bicarbonate or lactate proved to be strong predictors for rapid death in the univariate analysis, only the multivariate ML model was able to reliably differentiate the disease course of the long-stay outcome population (AUC of 0.77). We demonstrate the feasibility of prospective patient stratification using ML algorithms in the by far largest ARDS cohort reported to date. Our algorithm can identify patients with sufficiently long ARDS episodes to allow time for patients to respond to therapy, increasing statistical power. Further, early enrollment alerts may increase recruitment rate.


  • Top Cited Papers
    Open Access

    Multivariable Association Discovery in Population-scale Meta-omics Studies

    by Himel Mallick, Ali Rahnavard, Lauren J. McIver, Siyuan Ma, Yancong Zhang, Long H. Nguyen, Timothy L. Tickle, George Weingart, Boyu Ren, Emma H. Schwager, et al.

    It is challenging to associate features such as human health outcomes, diet, environmental conditions, or other metadata to microbial community measurements, due in part to their quantitative properties. Microbiome multi-omics are typically noisy, sparse (zero-inflated), high-dimensional, extremely non-normal, and often in the form of count or compositional measurements. Here we introduce an optimized combination of novel and established methodology to assess multivariable association of microbial community features with complex metadata in population-scale observational studies. Our approach, MaAsLin 2 (Microbiome Multivariable Associations with Linear Models), uses general linear models to accommodate a wide variety of modern epidemiological studies, including cross-sectional and longitudinal designs, as well as a variety of data types (e.g. counts and relative abundances) with or without covariates and repeated measurements. To construct this method, we conducted a large-scale evaluation of a broad range of scenarios under which straightforward identification of meta-omics associations can be challenging. These simulation studies reveal that MaAsLin 2’s linear model preserves statistical power in the presence of repeated measures and multiple covariates, while accounting for the nuances of meta-omics features and controlling false discovery. We also applied MaAsLin 2 to a microbial multi-omics dataset from the Integrative Human Microbiome (HMP2) project which, in addition to reproducing established results, revealed a unique, integrated landscape of inflammatory bowel disease (IBD) across multiple time points and omics profiles.


  • Open Access

    Predicting acute kidney injury in critically ill patients using comorbid conditions utilizing machine learning

    by Khaled Shawwa, Erina Ghosh, Stephanie Lanius, Emma Schwager, Larry Eshelman, Kianoush B Kashani

    Background: Acute kidney injury (AKI) carries a poor prognosis. Its incidence is increasing in the intensive care unit (ICU). Our purpose in this study is to develop and externally validate a model for predicting AKI in the ICU using patient data present prior to ICU admission. Methods: We used data of 98 472 adult ICU admissions at Mayo Clinic between 1 January 2005 and 31 December 2017 and 51 801 encounters from Medical Information Mart for Intensive Care III (MIMIC-III) cohort. A gradient-boosting model was trained on 80% of the Mayo Clinic cohort using a set of features to predict AKI acquired in the ICU. Results: AKI was identified in 39 307 (39.9%) encounters in the Mayo Clinic cohort. Patients who developed AKI in the ICU were older and had higher ICU and in-hospital mortality compared to patients without AKI. A 30-feature model yielded an area under the receiver operating curve of 0.690 [95% confidence interval (CI) 0.682–0.697] in the Mayo Clinic cohort set and 0.656 (95% CI 0.648–0.664) in the MIMIC-III cohort. Conclusions: Using machine learning, AKI among ICU patients can be predicted using information available prior to admission. This model is independent of ICU information, making it valuable for stratifying patients at admission.


  • Open Access

    A Bayesian method for detecting pairwise associations in compositional data

    by Emma Schwager, Himel Mallick, Steffen Ventz, Curtis Huttenhower

    Compositional data consist of vectors of proportions normalized to a constant sum from a basis of unobserved counts. The sum constraint makes inference on correlations between unconstrained features challenging due to the information loss from normalization. However, such correlations are of long-standing interest in fields including ecology. We propose a novel Bayesian framework (BAnOCC: Bayesian Analysis of Compositional Covariance) to estimate a sparse precision matrix through a LASSO prior. The resulting posterior, generated by MCMC sampling, allows uncertainty quantification of any function of the precision matrix, including the correlation matrix. We also use a first-order Taylor expansion to approximate the transformation from the unobserved counts to the composition in order to investigate what characteristics of the unobserved counts can make the correlations more or less difficult to infer. On simulated datasets, we show that BAnOCC infers the true network as well as previous methods while offering the advantage of posterior inference. Larger and more realistic simulated datasets further showed that BAnOCC performs well as measured by type I and type II error rates. Finally, we apply BAnOCC to a microbial ecology dataset from the Human Microbiome Project, which in addition to reproducing established ecological results revealed unique, competition-based roles for Proteobacteria in multiple distinct habitats. Data from many fields are available primarily in the form of proportions, also referred to as compositions, which impose mathematical constraints on identifying interactions among components in the underlying systems. In particular, correlations cannot be calculated directly from proportions or from count data that give rise to them. Methods that work around this difficulty generally do so by imposing strong assumptions about the distribution of underlying data or associated correlations, and these in turn often prevent quantifying uncertainty in the resulting estimates of correlation. We developed a statistical model (BAnOCC: Bayesian Analysis of Compositional Covariance) that both estimates correlations between counts or proportions and provides a posterior distribution for each correlation that quantifies how uncertain the estimate is. BAnOCC does well at controlling the number of false positives in simulated data and can be practically applied to a wide range of proportional data types.


  • Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium

    by The Microbiome Quality Control Project Consortium, Rashmi Sinha, Galeb Abu-Ali, Emily Vogtmann, Anthony A Fodor, Boyu Ren, Amnon Amir, Emma Schwager, Jonathan Crabtree, Siyuan Ma, et al.

    The Microbiome Quality Control project consortium reports outcomes of a baseline study (MBQC) that will guide future improvements in reproducibility of microbiome analyses. In order for human microbiome studies to translate into actionable outcomes for health, meta-analysis of reproducible data from population-scale cohorts is needed. Achieving sufficient reproducibility in microbiome research has proven challenging. We report a baseline investigation of variability in taxonomic profiling for the Microbiome Quality Control (MBQC) project baseline study (MBQC-base). Blinded specimen sets from human stool, chemostats, and artificial microbial communities were sequenced by 15 laboratories and analyzed using nine bioinformatics protocols. Variability depended most on biospecimen type and origin, followed by DNA extraction, sample handling environment, and bioinformatics. Analysis of artificial community specimens revealed differences in extraction efficiency and bioinformatic classification. These results may guide researchers in experimental design choices for gut microbiome studies.